Your browser doesn't support javascript.
loading
Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA.
Penzenstadler, Justin; Earp, Justin C; Wood Heickman, Lauren K; Pluchino, Kristen.
  • Penzenstadler J; Division of Diabetes, Lipid Disorders, and Obesity, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. justin.penzenstadler@fda.hhs.gov.
  • Earp JC; Division of Pharmacometrics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Wood Heickman LK; Division of Diabetes, Lipid Disorders, and Obesity, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Pluchino K; Division of Diabetes, Lipid Disorders, and Obesity, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Diabetologia ; 66(3): 603-604, 2023 03.
Article en En | MEDLINE | ID: mdl-36542112
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Islotes Pancreáticos / Diabetes Mellitus Tipo 1 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Islotes Pancreáticos / Diabetes Mellitus Tipo 1 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article